Very early researchActive Not RecruitingNCT05469009
What this trial is testing
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease 1
Ali Rezai 15